Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and NK Immunotherapy for Recurrent Ovarian Cancer
NCT02849353Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of HANK cells in recurrent ovarian cancer (ROC), sponsored by Fuda Cancer Hospital. Started Jul 2016; status: completed.
02
Drugs
HANK cells
03
Conditions
recurrent ovarian cancer (ROC)
Beyond the preview
Go deeper on NCT02849353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849353.